Inventor · disambiguated record
Timothy Richard Coon
Also filed as: COON TIMOTHY · COON TIMOTHY R · COON TIMOTHY RICHARD
26 granted patents·12 pending applications·170 citations·filing 2005–2025
96Inventor score
Top patents by PatentIndex Score
38 records- 0197US11591350B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Feb 28, 2023·7 cites·27 claims
- 0297US11584761B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Feb 21, 2023·9 cites·37 claims
- 0397US10758534B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2019·Granted Sep 1, 2020·13 cites·38 claims
- 0497US10258624B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Apr 16, 2019·32 cites·47 claims
- 0597US9782408B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2015·Granted Oct 10, 2017·33 cites·84 claims
- 0696US11873300B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2020·Granted Jan 16, 2024·6 cites·25 claims
- 0796US11426407B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Granted Aug 30, 2022·6 cites·47 claims
- 0895US11066417B2Modulators of cystic fibrosis transmembrane conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2019·Granted Jul 20, 2021·13 cites·47 claims
- 0994US11866450B2Modulators of Cystic Fibrosis Transmembrane Conductance regulator, pharmaceutical compositions, methods of treatment, and process for making the modulatorsVERTEX PHARMA·Filed 2021·Granted Jan 9, 2024·3 cites·41 claims
- 1094US9422310B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2015·Granted Aug 23, 2016·14 cites·19 claims
- 1193US12168009B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2022·Granted Dec 17, 2024·1 cites·46 claims
- 1293US12122788B2Process of making CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Oct 22, 2024·1 cites·21 claims
- 1391US10738030B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2017·Granted Aug 11, 2020·6 cites·48 claims
- 1489US8084614B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2008·Granted Dec 27, 2011·12 cites·17 claims
- 1588US2025205232A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 1685US12319693B2Crystalline forms of CFTR modulatorsVERTEX PHARMA·Filed 2023·Granted Jun 3, 2025·0 cites·20 claims
- 1785US10941159B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2019·Granted Mar 9, 2021·1 cites·4 claims
- 1885US8481738B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2011·Granted Jul 9, 2013·6 cites·9 claims
- 1983US10336769B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2017·Granted Jul 2, 2019·2 cites·1 claims
- 2083US8952161B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2013·Granted Feb 10, 2015·4 cites·16 claims
- 2178US2024368189A1Modulators of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods of Treatment, and Process for Making the ModulatorsVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2276US11713324B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Aug 1, 2023·0 cites·2 claims
- 2376US2025282792A1Gonadotropin-releasing hormone receptor antagonists and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2025·Application pending·0 cites
- 2474US2025179091A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2024·Application pending·0 cites
- 2564US12269831B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Granted Apr 8, 2025·0 cites·41 claims
- 2664US2025340574A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2761US2025122218A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2023·Application pending·0 cites
- 2859US8293729B2Compounds, pharmaceutical composition and methods relating theretoDYCK BRIAN·Filed 2010·Granted Oct 23, 2012·1 cites·20 claims
- 2956US12324802B2Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Granted Jun 10, 2025·0 cites·53 claims
- 3056US8263588B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2008·Granted Sep 11, 2012·0 cites·18 claims
- 3156US2023382925A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3256US2024018161A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3356US2023374038A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3456US2024150377A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2021·Application pending·0 cites
- 3553US2022047564A1Methods of treatment for cystic fibrosisVERTEX PHARMA·Filed 2019·Application pending·0 cites
- 3650US2022313698A1Modulators of cystic fibrosis transmembrane conductance regulatorVERTEX PHARMA·Filed 2020·Application pending·0 cites
- 3748US8507536B2Gonadotropin-releasing hormone receptor antagonists and methods relating theretoBEATON GRAHAM·Filed 2012·Granted Aug 13, 2013·0 cites·16 claims
- 3843US7393865B2Sleep inducing compounds and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2005·Granted Jul 1, 2008·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Timothy Richard Coon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →